Recruiting Type 2 Diabetes Studies in Waterbury
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
The study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which ca...
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and sa...
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes....
About Type 2 Diabetes Clinical Trials in Waterbury
Type 2 diabetes is a chronic metabolic condition affecting over 37 million Americans, characterized by insulin resistance and progressive loss of beta-cell function. While metformin remains the first-line treatment, the treatment landscape has expanded dramatically with GLP-1 receptor agonists (semaglutide, tirzepatide), SGLT2 inhibitors (empagliflozin, dapagliflozin), and dual GIP/GLP-1 agonists showing both glycemic and cardiovascular benefits. Clinical trials are now exploring triple-hormone agonists, oral GLP-1 formulations, islet cell regeneration therapies, and precision medicine approaches that tailor treatment to individual metabolic profiles. Patients with uncontrolled HbA1c on current medications, those with diabetic complications, or newly diagnosed patients may qualify for enrollment.
There are currently 3 type 2 diabetes clinical trials recruiting participants in Waterbury, CONNECTICUT. These studies are seeking a combined 888 participants. Research is being sponsored by Novo Nordisk A/S, Hoffmann-La Roche, Zealand Pharma. Clinical trial participation is free and participants receive study-related medical care at no cost.
Type 2 Diabetes Clinical Trials in Waterbury — FAQ
Are there type 2 diabetes clinical trials in Waterbury?
Yes, there are 3 type 2 diabetes clinical trials currently recruiting in Waterbury, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Waterbury?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Waterbury research site will contact you about next steps.
Are clinical trials in Waterbury free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Waterbury studies also compensate for your time and travel.
What type 2 diabetes treatments are being tested?
The 3 active trials in Waterbury are testing new therapies including novel drugs, biologics, and treatment approaches for type 2 diabetes.
Data updated March 2, 2026 from ClinicalTrials.gov